Loading...
XNYSCNC
Market cap30bUSD
Dec 26, Last price  
60.91USD
1D
0.13%
1Q
-18.33%
Jan 2017
115.61%
Name

Centene Corp

Chart & Performance

D1W1MN
XNYS:CNC chart
P/E
11.38
P/S
0.20
EPS
5.35
Div Yield, %
0.00%
Shrs. gr., 5y
6.49%
Rev. gr., 5y
20.70%
Revenues
154.00b
+6.54%
1,000,940,0001,505,864,0002,279,020,0002,919,292,0003,364,515,0004,102,864,0004,448,323,0005,340,582,0008,667,612,00010,863,329,00016,560,000,00022,760,000,00040,607,000,00048,382,000,00060,116,000,00074,639,000,000111,115,000,000125,982,000,000144,547,000,000153,999,000,000
Net income
2.70b
+124.79%
44,312,00055,632,000-43,629,00073,402,00083,497,00083,671,00094,836,000111,218,0001,859,000165,099,000271,000,000355,000,000562,000,000828,000,000900,000,0001,321,000,0001,808,000,0001,347,000,0001,202,000,0002,702,000,000
CFO
8.05b
+28.62%
99,405,00074,048,000195,032,000202,240,000221,978,000248,195,000168,932,000261,696,000278,691,000382,526,0001,223,000,000658,000,0001,851,000,0001,489,000,0001,234,000,0001,483,000,0005,503,000,0004,205,000,0006,261,000,0008,053,000,000
Earnings
Feb 04, 2025

Profile

Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions and limited over-the-counter drugs, medical equipment, and behavioral health and abuse services. This segment also offers various individual, small group, and large group commercial healthcare products to employers and directly to members. The company's Specialty Services segment provides pharmacy benefits management services; nurse advice line and after-hours support services; vision and dental services, as well as staffing services to correctional systems and other government agencies; and services to Military Health System eligible beneficiaries. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.
IPO date
Dec 13, 2001
Employees
74,300
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
153,999,000
6.54%
144,547,000
14.74%
125,982,000
13.38%
Cost of revenue
122,458,000
127,891,000
121,949,000
Unusual Expense (Income)
NOPBT
31,541,000
16,656,000
4,033,000
NOPBT Margin
20.48%
11.52%
3.20%
Operating Taxes
899,000
760,000
477,000
Tax Rate
2.85%
4.56%
11.83%
NOPAT
30,642,000
15,896,000
3,556,000
Net income
2,702,000
124.79%
1,202,000
-10.76%
1,347,000
-25.50%
Dividends
Dividend yield
Proceeds from repurchase of equity
(1,589,000)
(3,026,000)
(262,000)
BB yield
3.92%
6.34%
0.54%
Debt
Debt current
287,000
82,000
267,000
Long-term debt
19,638,000
21,251,000
22,190,000
Deferred revenue
Other long-term liabilities
2,738,000
5,616,000
5,610,000
Net debt
(16,013,000)
(7,746,000)
(6,243,000)
Cash flow
Cash from operating activities
8,053,000
6,261,000
4,205,000
CAPEX
(799,000)
(1,004,000)
(910,000)
Cash from investing activities
(1,191,000)
(2,921,000)
(3,299,000)
Cash from financing activities
(1,658,000)
(4,197,000)
1,362,000
FCF
30,659,000
16,855,000
2,939,000
Balance
Cash
19,652,000
14,395,000
14,657,000
Long term investments
16,286,000
14,684,000
14,043,000
Excess cash
28,238,050
21,851,650
22,400,900
Stockholders' equity
11,508,000
8,390,000
8,444,000
Invested Capital
36,231,000
39,483,000
43,026,000
ROIC
80.94%
38.53%
8.74%
ROCE
65.19%
34.35%
7.63%
EV
Common stock shares outstanding
545,704
582,040
590,516
Price
74.21
-9.51%
82.01
-0.47%
82.40
37.26%
Market cap
40,496,694
-15.16%
47,733,100
-1.90%
48,658,518
39.96%
EV
24,599,694
40,167,100
42,642,518
EBITDA
32,834,000
18,209,000
5,509,000
EV/EBITDA
0.75
2.21
7.74
Interest
725,000
665,000
665,000
Interest/NOPBT
2.30%
3.99%
16.49%